PCR for Diagnosing and Monitoring Sleeping Sickness
Author Information
Author(s): Stijn Deborggraeve, Veerle Lejon, Rosine Ali Ekangu, Dieudonné Mumba Ngoyi, Patient Pati Pyana, Médard Ilunga, Jean Pierre Mulunda, Philippe Büscher
Primary Institution: Institute of Tropical Medicine, Antwerp, Belgium
Hypothesis
Can PCR improve the diagnosis, staging, and post-treatment follow-up of sleeping sickness?
Conclusion
PCR is effective for diagnosing and staging sleeping sickness but is unreliable for post-treatment follow-up.
Supporting Evidence
- PCR on blood showed 88.4% sensitivity and 99.2% specificity for diagnosis.
- During follow-up, 20% of cured patients had persistent PCR positivity.
- PCR on CSF had 88.4% sensitivity for staging but was unreliable for treatment follow-up.
Takeaway
Scientists tested a new method called PCR to see if it could help doctors find and track a disease called sleeping sickness better than old methods. They found it works well for finding the disease but not so well for checking if patients are cured.
Methodology
PCR was performed on blood and cerebrospinal fluid of 360 sleeping sickness patients and 129 controls, assessing sensitivity and specificity over 2 years.
Potential Biases
Potential overestimation of PCR sensitivity due to inclusion criteria favoring patients with higher parasitemia.
Limitations
The study included a mix of primary and retreatment cases, which may affect sensitivity estimates.
Participant Demographics
Patients were aged 12 and older, with a mix of primary and retreatment cases from the Democratic Republic of the Congo.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website